Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells.

Cancer immunology, immunotherapy : CII - 1 Nov 2008

Stoitzner Patrizia, Green Laura K, Jung Jae Y, Price Kylie M, Atarea Haley, Kivell Bronwyn, Ronchese Franca

Abstract excerpt

BACKGROUND: Transplantable B16 melanoma is widely used as a tumor model to investigate tumor immunity. We wished to characterize the leukocyte populations infiltrating B16 melanoma tumors, and the functional properties of tumor-infiltrating dendritic cells (TIDC). MATERIALS AND METHODS: We used t...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen Presentation
Share to Antigen-Presenting Cells
Share to Leukocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymph Nodes

Share to Lymphocytes, Tumor-Infiltrating

Share to Melanoma, Experimental

Share to Ovalbumin

Share to T-Lymphocytes, Cytotoxic

Source

Open in PubMed Open full text

Identifiers

PMID: 18311487
DOI: 10.1007/s00262-008-0487-4
PMCID: PMC11029823

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18311487-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells.PMID 18311487Read ↗

Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression. A role in the immune tolerance to antigenic tumors.Semantic proximity Read ↗

Antigen presentation requirements for effective cDC1-based cancer immunotherapySemantic proximity Read ↗

Tumor-infiltrating dendritic cells in cancer pathogenesis.Semantic proximity Read ↗

Murine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cells.Semantic proximity Read ↗

Dendritic cell vaccines in melanoma: from promise to proof?Semantic proximity Read ↗

Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.Semantic proximity Read ↗

Surface phenotype and functions of tumor-infiltrating dendritic cells: CD8 expression by a cell subpopulation.Semantic proximity Read ↗

Induction of potent antitumor immunity by in situ targeting of intratumoral DCs.Semantic proximity Read ↗

Phagocytosis by dendritic cells rather than MHC IIhigh macrophages is associated with skin tumour regression.Semantic proximity Read ↗

Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.Semantic proximity Read ↗

TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.Semantic proximity Read ↗

Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.